Brivanib-impurities | Pharmaffiliates

brivanib and its Impurities

"Brivanib has been investigated for the treatment of Solid Tumors, Hepato Cellular Carcinoma (HCC), and Metastatic Colorectal Cancer (MCRC). It is under investigation for the treatment of HepatoCellular Carcinoma. . Reference standards of Brivanib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below

Displaying 4 results for brivanib Impurities
PA 02 45000

Brivanib - API

Brivanib


  • Catalogue No.:PA 02 45000

  • CAS :

    649735-46-6

  • Molecular Formula : C19H19FN4O3

  • Molecular Weight : 370.38

PA 02 45510

Brivanib Alaninate

Brivanib Alaninate


  • Catalogue No.:PA 02 45510

  • CAS :

    649735-63-7

  • Molecular Formula : C22H24FN5O4

  • Molecular Weight : 441.46

PA STI 088922

1-((4-((4-Fluoro-2-methyl-1H-indol-5-yl)oxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl)oxy)propan-2,3,3,3-d4-2-ol

1-((4-((4-Fluoro-2-methyl-1H-indol-5-yl)oxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl)oxy)propan-2,3,3,3-d4-2-ol


  • Catalogue No.:PA STI 088922

  • CAS :

    NA

  • Molecular Formula : C19H15D4FN4O3

  • Molecular Weight : 374.41

PA STI 088923

Brivanib alaninate-d4

Brivanib alaninate-d4


  • Catalogue No.:PA STI 088923

  • CAS :

    NA

  • Molecular Formula : C22H20D4FN5O4

  • Molecular Weight : 445.49